ArticleScientific reports2022

Single-center prospective study on the efficacy of nivolumab against platinum-sensitive recurrent or metastatic head and neck squamous cell carcinoma.

Isaku Okamoto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.